CK Life Sciences Int'l., (Holdings) Inc. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was HKD 2,540.58 million compared to HKD 2,638.39 million a year ago. Net income was HKD 65.12 million compared to HKD 100.39 million a year ago. Basic earnings per share from continuing operations was HKD 0.0068 compared to HKD 0.0104 a year ago. Diluted earnings per share from continuing operations was HKD 0.0068 compared to HKD 0.0104 a year ago.